Adaptive DBS for Parkinson's disease
Official title: Adaptive vs Conventional Deep Brain Stimulation for Parkinson's Disease: A Multi-center Randomized Controlled Trial
Run by Beijing Pins Medical Co., Ltd · NCT07635823 · Data updated 2026-11-12
This study tests an adaptive, closed-loop deep brain stimulation system to see if it can better control Parkinson’s symptoms and improve quality of life compared to standard fixed stimulation in adults with Parkinson’s disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Beijing Pins Medical Co., Ltd Industry-sponsored |
| Locations | 9 sites (Hefei, Anhui and 8 other locations) |
| Status | Recruiting |
| Started | May 16, 2026 |
| Main results expected | May 31, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT07635823 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with idiopathic Parkinson’s disease, HY 2.5–4 off medication, who are DBS candidates (bilateral STN or GPi) or who have had prior DBS with one IPG and are eligible for device replacement to the G1010R system.
✕Probably not a fit
Patients unable to undergo DBS surgery or with significant cognitive or medical contraindications may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, randomized, double‑blind crossover study compares an adaptive closed-loop DBS system (aDBS) using real-time brain signals and sleep data to conventional open-loop DBS in people with Parkinson’s disease. Participants will receive a PINS Medical G1010R neurostimulator implant and experience both stimulation modes in alternating phases. Outcomes include dyskinesia duration, off time, motor symptoms, sleep quality, and overall quality of life, with safety monitoring throughout. The trial comprises screening, surgery, DBS optimization for both modalities, crossover evaluation, and long‑term follow-up across multiple visits.
Why it matters
Potential benefit: If successful, the adaptive DBS approach could reduce troublesome dyskinesia and improve daily functioning and sleep for people with Parkinson’s disease.
How similar studies have gone: Previous DBS trials show benefit from closed-loop concepts in movement disorders, but this adaptive approach with real-time brain signal feedback is an innovative, relatively novel strategy in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * idiopathic Parkinson's disease * Hoehn \& Yahr (HY) stage 2.5-4 during medication "OFF" * Subjects must meet one of the following: 1. Never underwent DBS surgery and suitable for bilateral STN or GPi DBS surgery; 2. Previous bilateral STN/GPi DBS recipients with only one IPG who: * Demonstrate responsiveness to conventional cDBS therapy per investigator evaluation, * Consent to device replacement with G1010R DBS system. * Willing and physically/mentally able to complete all study visits and procedures * Capable of comprehending and providing written informed consent Exclusion Criteria: * Presence of contraindications to deep brain stimulation (DBS) surgery. * Beck Depression Inventory-II (BDI-II) score \> 25 * Mini-Mental State Examination (MMSE) score \< 24 (adjusted for educational level) * Significant comorbidities that may interfere with DBS therapy per investigator assessment. * Pre-existing active non-DBS medical implants or metallic cranial implants * Requirement for diathermy, transcranial magnetic stimulation (TMS), or electroconvulsive therapy (ECT) during the study period * History of ablative neurosurgery or stem cell therapy for Parkinson's disease * Inability to complete ≥3 consecutive days of comprehensive motor/sleep diaries * Inability to maintain prescribed medication regimens or comply with protocol requirements * Current pregnancy, lactation, or planned pregnancy during the study period * Other conditions deemed by investigators to compromise study suitability * Participation in other interventional clinical trials within 4 weeks prior to consent
Where it's running
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting -
Nanjing Brain Hospital
Nanjing, Jiangsu, China Recruiting -
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hefei, Anhui, China Not yet recruiting -
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China Not yet recruiting
Show 3 more locations
-
First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China Not yet recruiting -
Qilu Hospital of Shandong University
Jinan, Shandong, China Not yet recruiting -
West China Hospital
Chengdu, Sichuan, China Not yet recruiting
Study contacts
- Study coordinator: Jianguang Sun
- Email: sunjianguang@pinsmedical.com
- Phone: +86 010-60736388
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using DANU smart socks to measure walking, balance, and fall risk in Parkinson's
This project will test whether DANU smart socks can accurately measure gait and balance and help predict falls in people with Parkinson's.
-
Boosting empathy and self-compassion for people with Parkinson's and their caregivers
This project will try a six-week empathy and self-compassion training to see if it improves quality of life for people with Parkinson's and their regular caregivers.
-
Spinal cord stimulation to help post-stroke spasticity
This study tests whether active spinal cord stimulation can reduce limb spasticity after stroke compared with a sham treatment in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.